Our studies and those of others with AR-transgenic mice have demonstrated that the increased lens-directed expression of AR leads to an increased incidence of cataracts after the induction of experimental diabetes or following galactose feeding, unlike nontransgenic littermates with basal levels of AR [6,14]. The gene discussed is AR; the disease is cataract.